Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases

FEBS Journal

Volumn 276, Issue 16, 2009, Pages 4395-4404

  Davis, Tara L ^a,b   Walker, John R ^a   Allali Hassani, Abdellah ^a   Parker, Sirlester A ^c   Turk, Benjamin E ^c   Dhe Paganon, Sirano ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ephrin kinase; Peptide array; Receptor tyrosine kinase; Substrate recognition; X ray crystallography

Indexed keywords

EPHRIN; EPHRIN RECEPTOR A3; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ARTICLE; CELL ADHESION; CELL INTERACTION; CRYSTALLIZATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; PRIORITY JOURNAL;

CRYSTALLOGRAPHY, X-RAY; EPHRINS; HUMANS; NEOPLASM PROTEINS; PEPTIDE LIBRARY; PROTEIN BINDING; RECEPTOR PROTEIN-TYROSINE KINASES; SUBSTRATE SPECIFICITY;

EID: 68749104879     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07147.x     Document Type: Article

References (36)

1. Himanen JP, Saha N Nikolov DB (2007) Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol 19, 534 542.
2. Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133, 38 52.
3. Surawska H, Ma PC Salgia R (2004) The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15, 419 433.
4. Lackmann M Boyd AW (2008) Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal 1, re2.
5. Noren NK Pasquale EB (2004) Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 16, 655 666.
6. Smith FM, Vearing C, Lackmann M, Treutlein H, Himanen J, Chen K, Saul A, Nikolov D Boyd AW (2004) Dissecting the EphA3/ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem 279, 9522 9531.
7. Clifford N, Smith L, Powell J, Gattenlöhner S, Marx A O'Connor R (2008) The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration. J Cell Biochem 105, 1250 1259.
8. Cheng H-J, Nakamoto M, Bergemann AD Flanagan JG (1995) Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map. Cell 82, 371 381.
9. Feldheim DA, Nakamoto M, Osterfield M, Gale NW, DeChiara TM, Rohatgi R, Yancopoulos GD Flanagan JG (2004) Loss-of-function analysis of EphA receptors in retinotectal mapping. J Neurosci 24, 2542 2550.
10. Lai C Lemke G (1991) An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6, 691 704.
11. Stephen LJ, Fawkes AL, Verhoeve A, Lemke G Brown A (2007) A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev Biol 302, 66 79.
12. Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler KW et al. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949.
13. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069 1075.
14. Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM, Riggins GJ, Wang TL, Yan H, Gazdar A et al. (2006) Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum Mutat 27, 1060 1061.
15. Balakrishnan A, Bleeker FE, Lamba S, Rodolfo M, Daniotti M, Scarpa A, van Tilborg AA, Leenstra S, Zanon C Bardelli A (2007) Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res 67, 3545 3550.
16. Fox BP, Tabone CJ Kandpal RP (2006) Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines. Biochem Biophys Res Commun 342, 1263 1272.
17. Day B, To C, Himanen JP, Smith FM, Nikolov DB, Boyd AW Lackmann M (2005) Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J Biol Chem 280, 26526 26532.
18. Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, Vearing C, Geleick D, Feldheim DA, Boyd AW et al. (2004) Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling [see comment]. Nat Neurosci 7, 501 509.
19. Murai KK Pasquale EB (2003) 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci 116, 2823 2832.
20. Davis TL, Walker JR, Loppnau P, Butler-Cole C, Allali-Hassani A Dhe-Paganon S (2008) Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3). Structure 16, 873 884.
21. Hubbard SR (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16, 5572 5581.
22. Warner N, Wybenga-Groot LE Pawson T (2008) Analysis of EphA4 receptor tyrosine kinase substrate specificity using peptide-based arrays. FEBS J 275, 2561 2573.
23. Minor W, Cymborowski M Otwinowski Z (2002) Automatic system for crystallographic data collection and analysis. Acta Physiol Pol 101, 613 619.
24. Otwinowski Z Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307 326.
25. Leslie AG (2006) The integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr 62, 48 57.
26. Evans P (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62, 72 82.
27. Read RJ (2001) Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr D Biol Crystallogr 57, 1373 1382.
28. Emsley P Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126 2132.
29. Potterton E, Briggs P, Turkenburg M Dodson E (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59, 1131 1137.
30. Winn MD, Isupov MN Murshudov GN (2001) Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57, 122 133.
31. Collaborative Computational Project, Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760 763.
32. Laskowski RA, Macarthur MW, Moss DS Thornton JM (1993) Procheck - a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26, 283 291.
33. Davis IW, Murray LW, Richardson JS Richardson DC (2004) MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res 32, W615 W619.
34. Hutti JE, Jarrell ET, Chang JD, Abbott DW, Storz P, Toker A, Cantley LC Turk BE (2004) A rapid method for determining protein kinase phosphorylation specificity. Nat Methods 1, 27 29.
35. Jeanmougin F, Thompson JD, Gouy M, Higgins DG Gibson TJ (1998) Multiple sequence alignment with Clustal X. Trends Biochem Sci 23, 403 405.
36. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F Higgins DG (1997) The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876 4882.